K Win, Y Thwe, T T Lwin, K Win. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdolescentAdultAntimalarials/administration & dosageAntimalarials/therapeutic useClinical Trials as TopicDrug CombinationsDrug Resistance, MicrobialDrug Therapy, CombinationHumansMalaria/parasitologyMalaria/prevention & controlMaleMefloquinePlasmodium falciparum/isolation & purificationPlasmodium vivax/isolation & purificationPyrimethamine/administration & dosagePyrimethamine/therapeutic useQuinolines/administration & dosageQuinolines/therapeutic useSulfadoxine/administration & dosageSulfadoxine/therapeutic useSulfanilamides/administration & dosage
Substances: See more » AntimalarialsDrug CombinationsQuinolinesSulfanilamidesSulfadoxineMefloquinePyrimethamine
Year: 1985 PMID: 2863679 DOI: 10.1016/s0140-6736(85)92933-2
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321